Tofacitinib in Patients with Rheumatoid Arthritis: Single-center Experience Rheumatoid Arthritis and Tofacitinib

Authors :: Serdar Sezer
Emine Gözde Aydemir Gülöksüz
Murat Turgay
Gülay Kinikli
Murat Torgutalp
Aşkın Ateş
Müçteba Enes Yayla
Didem Şahin
Mehmet Levent Yüksel
Ayşe Bahar Keleşoğlu Dinçer
Source :: Ankara Üniversitesi Tıp Fakültesi Mecmuas, Vol 73, Iss 1, Pp 20-25 (2020)
Publication Year :: 2020
Publisher :: Galenos Yayinevi, 2020.
Abstract: Objectives:In this study, we aimed to determine the clinical, laboratory and demographic characteristics of patients with rheumatoid arthritis (RA) using tofacitinib, and the drug survival rates.Materials and Methods:A total of 78 RA patients who were prescribed tofacitinib between May 2016 and July 2019 were retrospectively evaluated and included in the study. The clinical, laboratory and demographic features of the patients were recorded. Drug survival rates were analyzed using Kaplan-Meier survival analysis. P

Subjects :: rheumatoid arthritis
lcsh:R5-920
medicine.medical_specialty
tofacitinib
Tofacitinib
business.industry
Single Center
medicine.disease
Dermatology
drug survival
Rheumatoid arthritis
Medicine
In patient
lcsh:Medicine (General)
business

Full Text Access

Tools